La liste des publications est mise à jour tous les jours via PubMed et seules les publications les plus récentes sont affichées sur cette page. Cette list contient seulement les articles de revue. Une liste (Publications récentes) incluant tous les articles est également disponible.

CBT

  1. van Griensven, J., Diro, E. & Yansouni, C. P. (2022). Hidden sources of bias in diagnostic studies: the example of visceral leishmaniasis in east Africa. The Lancet. Infectious diseases.
  2. Ortiz-Brizuela, E., Menzies, D. & Behr, M. A. (2022). Testing and Treating Mycobacterium tuberculosis Infection. The Medical clinics of North America, vol. 106, p. 929-947.
  3. Liu, S., Le Mauff, F., Sheppard, D. C. & Zhang, S. (2022). Filamentous fungal biofilms: Conserved and unique aspects of extracellular matrix composition, mechanisms of drug resistance and regulatory networks in Aspergillus fumigatus. NPJ biofilms and microbiomes, vol. 8, p. 83.
  4. Motamedi, M., Ferrara, G., Yacyshyn, E., Osman, M., Abril, A., Rahman, S., Netchiporouk, E. & Gniadecki, R. (2022). Skin disorders and interstitial lung disease. Part I. Screening, Diagnosis and Therapeutic Principles. Journal of the American Academy of Dermatology.
  5. Ouchene, L., Muntyanu, A., Assayag, D., Veilleux, E., Abril, A., Ferrara, G., Yacyshyn, E., Pineau, C. A., O'Brien, E., Baron, M., Osman, M., Gniadecki, R. & Netchiporouk, E. (2022). Skin disorders and interstitial lung disease: Part II. The spectrum of cutaneous diseases with lung disease association. Journal of the American Academy of Dermatology.
  6. Lopez-Olivo, M. A., Valerio, V., Karpes Matusevich, A. R., Brizio, M., Kwok, M., Geng, Y., Suarez-Almazor, M. E. & Colmegna, I. (2022). Safety and Efficacy of Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitors. Systematic Review with Meta-Analysis. Vaccines, vol. 10.
  7. Mboumba Bouassa, R.-S., Sebastiani, G., Di Marzo, V., Jenabian, M.-A. & Costiniuk, C. T. (2022). Cannabinoids and Chronic Liver Diseases. International journal of molecular sciences, vol. 23.
  8. Ouyang, J., Zaongo, S. D., Harypursat, V., Li, X., Routy, J.-P. & Chen, Y. (2022). SARS-CoV-2 pre-exposure prophylaxis: A potential COVID-19 preventive strategy for high-risk populations, including healthcare workers, immunodeficient individuals, and poor vaccine responders. Frontiers in public health, vol. 10, p. 945448.
  9. Solomon, M. & Liang, C. (2022). Human coronaviruses: The emergence of SARS-CoV-2 and management of COVID-19. Virus research, vol. 319, p. 198882.
  10. Bai, A. D., Lo, C. K., Komorowski, A. S., Suresh, M., Guo, K., Garg, A., Tandon, P., Senecal, J., Corpo, O. D., Stefanova, I., Fogarty, C., Butler-Laporte, G., McDonald, E. G., Cheng, M. P., Morris, A. M., Loeb, M. & Lee, T. C. (2022). Staphylococcus aureus bacteremia mortality across country income groups: A secondary analysis of a systematic review. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, vol. 122, p. 405-411.
  11. Garcia-Basteiro, A. L., White, R. G., Tait, D., Schmidt, A. C., Rangaka, M. X., Quaife, M., Nemes, E., Mogg, R., Hill, P. C., Harris, R. C., Hanekom, W. A., Frick, M., Fiore-Gartland, A., Evans, T., Dagnew, A. F., Churchyard, G., Cobelens, F., Behr, M. A. & Hatherill, M. (2022). End-point definition and trial design to advance tuberculosis vaccine development. European respiratory review : an official journal of the European Respiratory Society, vol. 31.
  12. Dowdy, D. W. & Behr, M. A. (2022). Are we underestimating the annual risk of infection with Mycobacterium tuberculosis in high-burden settings?. The Lancet. Infectious diseases, vol. 22, p. e271-e278.
  13. Merati, N., Sivachandran, S., Jfri, A., Ben-Shoshan, M., Vinh, D. C., Popradi, G. & Litvinov, I. V. (2022). Plerixafor on a WHIM - Promise or Fantasy of a New CXCR4 Inhibitor for This Rare, but Important Syndrome?. Skin therapy letter, vol. 27, p. 1-5.
  14. Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., Gurr, S. J., Harrison, T. S., Kuijper, E., Rhodes, J., Sheppard, D. C., Warris, A., White, P. L., Xu, J., Zwaan, B. & Verweij, P. E. (2022). Tackling the emerging threat of antifungal resistance to human health. Nature reviews. Microbiology, vol. 20, p. 557-571.
  15. Ahmed, D. S., Isnard, S., Berini, C., Lin, J., Routy, J.-P. & Royston, L. (2022). Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity. Frontiers in immunology, vol. 13, p. 820350.
  16. Gill, R. P. K., Gantchev, J., Martínez Villarreal, A., Ramchatesingh, B., Netchiporouk, E., Akilov, O. E., Ødum, N., Gniadecki, R., Koralov, S. B. & Litvinov, I. V. (2022). Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma. Cells, vol. 11.
  17. Renault, C., Veyrenche, N., Mennechet, F., Bedin, A.-S., Routy, J.-P., Van de Perre, P., Reynes, J. & Tuaillon, E. (2022). Th17 CD4+ T-Cell as a Preferential Target for HIV Reservoirs. Frontiers in immunology, vol. 13, p. 822576.
  18. Valantin, M.-A., Royston, L., Hentzien, M., Jary, A., Makinson, A., Veyri, M., Ronot-Bregigeon, S., Isnard, S., Palich, R. & Routy, J.-P. (2022). Therapeutic Perspectives in the Systemic Treatment of Kaposi's Sarcoma. Cancers, vol. 14.
  19. Kabir, A., Alizadehfar, R. & Tsoukas, C. M. (2021). Good's Syndrome: Time to Move on From Reviewing the Past. Frontiers in immunology, vol. 12, p. 815710.
  20. Alexandrova, Y., Costiniuk, C. T. & Jenabian, M.-A. (2021). Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection. Frontiers in immunology, vol. 12, p. 808722.
  21. McDonald, E. G., Butler-Laporte, G., Del Corpo, O., Hsu, J. M., Lawandi, A., Senecal, J., Sohani, Z. N., Cheng, M. P. & Lee, T. C. (2021). On the Treatment of Pneumocystis jirovecii Pneumonia: Current Practice Based on Outdated Evidence. Open forum infectious diseases, vol. 8, p. ofab545.
  22. Yan, J., Ouyang, J., Isnard, S., Zhou, X., Harypursat, V., Routy, J.-P. & Chen, Y. (2021). Alcohol Use and Abuse Conspires With HIV Infection to Aggravate Intestinal Dysbiosis and Increase Microbial Translocation in People Living With HIV: A Review. Frontiers in immunology, vol. 12, p. 741658.
  23. Carvalho Cabral, P., Tekade, K., Stegeman, S. K., Olivier, M. & Cermakian, N. (2022). The involvement of host circadian clocks in the regulation of the immune response to parasitic infections in mammals. Parasite immunology, vol. 44, p. e12903.
  24. Elkrief, A., Wu, J. T., Jani, C., Enriquez, K. T., Glover, M., Shah, M. R., Shaikh, H. G., Beeghly-Fadiel, A., French, B., Jhawar, S. R., Johnson, D. B., McKay, R. R., Rivera, D. R., Reuben, D. Y., Shah, S., Tinianov, S. L., Vinh, D. C., Mishra, S. & Warner, J. L. (2022). Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer. Cancer discovery, vol. 12, p. 303-330.
  25. Mouhoub, E., Domenech, P., Ndao, M. & Reed, M. B. (2021). The Diverse Applications of Recombinant BCG-Based Vaccines to Target Infectious Diseases Other Than Tuberculosis: An Overview. Frontiers in microbiology, vol. 12, p. 757858.

CRES

  1. Liu, J. L., Woo, J. M. P., Parks, C. G., Costenbader, K. H., Jacobsen, S. & Bernatsky, S. (2022). Systemic Lupus Erythematosus Risk: The Role of Environmental Factors. Rheumatic diseases clinics of North America, vol. 48, p. 827-843.
  2. Copaescu, A. M., Ben-Shoshan, M. & Trubiano, J. A. (2022). Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions. Frontiers in medicine, vol. 9, p. 923991.
  3. McDonald, E. G., Prosty, C., Hanula, R., Bortolussi-Courval NClin, É., Albuquerque, A., Tong, S. Y. C., Hamilton, F., Lee, T. C., McDonald, E. G., Prosty, C., Hanula, R., Bortolussi-Courval NClin, É., Albuquerque, A., Tong, S. Y. C., Hamilton, F. & Lee, T. C. (2022). Observational vs. Randomized Controlled Trials to Inform Antibiotic Treatment Durations:A Narrative Review. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
  4. Mboumba Bouassa, R.-S., Sebastiani, G., Di Marzo, V., Jenabian, M.-A. & Costiniuk, C. T. (2022). Cannabinoids and Chronic Liver Diseases. International journal of molecular sciences, vol. 23.
  5. Briller, J. E., Aggarwal, N. R., Davis, M. B., Hameed, A. B., Malhamé, I., Mahmoud, Z., McDonald, E. G., Moraes de Oliveira, G., Quesada, O., Scott, N. S., Sharma, J. & American College of Cardiology Cardiovascular Disease in Women Committee (2022). Cardiovascular Complications of Pregnancy-Associated COVID-19 Infections. JACC advances, p. 100057.
  6. Albuquerque, A. M., Eckert, I., Tramujas, L., Butler-Laporte, G., McDonald, E. G., Brophy, J. M. & Lee, T. C. (2022). Effect of Tocilizumab, Sarilumab, and Baricitinib on Mortality Among Patients Hospitalized for COVID-19 Treated with Corticosteroids: A Systematic Review and Meta-Analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
  7. Zimmer, A. J., Ugarte-Gil, C., Pathri, R., Dewan, P., Jaganath, D., Cattamanchi, A., Pai, M. & Grandjean Lapierre, S. (2022). Making cough count in tuberculosis care. Communications medicine, vol. 2, p. 83.
  8. Bai, A. D., Lo, C. K., Komorowski, A. S., Suresh, M., Guo, K., Garg, A., Tandon, P., Senecal, J., Corpo, O. D., Stefanova, I., Fogarty, C., Butler-Laporte, G., McDonald, E. G., Cheng, M. P., Morris, A. M., Loeb, M. & Lee, T. C. (2022). Staphylococcus aureus bacteremia mortality across country income groups: A secondary analysis of a systematic review. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, vol. 122, p. 405-411.
  9. Ensina, L. F., Brandão, L. S., Neto, H. C. & Ben-Shoshan, M. (2022). Urticaria and angioedema in children and adolescents: diagnostic challenge. Allergologia et immunopathologia, vol. 50, p. 17-29.
  10. Vaugon, E., Mircescu, A., Caya, C., Yao, M., Gore, G., Dendukuri, N. & Papenburg, J. (2022). Diagnostic accuracy of rapid one-step PCR assays for detection of herpes Simplex virus -1 and -2 in cerebrospinal fluid: A systematic Review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 28, p. 1547-1557.
  11. Lee, T. C., Murthy, S., Del Corpo, O., Senécal, J., Butler-Laporte, G., Sohani, Z. N., Brophy, J. M. & McDonald, E. G. (2022). Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 28, p. 1203-1210.
  12. Prosty, C., Copaescu, A. M., Gabrielli, S., Mule, P. & Ben-Shoshan, M. (2022). Pediatric Drug Allergy. Immunology and allergy clinics of North America, vol. 42, p. 433-452.
  13. Merati, N., Sivachandran, S., Jfri, A., Ben-Shoshan, M., Vinh, D. C., Popradi, G. & Litvinov, I. V. (2022). Plerixafor on a WHIM - Promise or Fantasy of a New CXCR4 Inhibitor for This Rare, but Important Syndrome?. Skin therapy letter, vol. 27, p. 1-5.
  14. McDonald, E. G., Butler-Laporte, G., Del Corpo, O., Hsu, J. M., Lawandi, A., Senecal, J., Sohani, Z. N., Cheng, M. P. & Lee, T. C. (2021). On the Treatment of Pneumocystis jirovecii Pneumonia: Current Practice Based on Outdated Evidence. Open forum infectious diseases, vol. 8, p. ofab545.
  15. Mo, S., Malhamé, I., Schneiderman, M. & Vinet, É. (2022). Pregnancy Termination in Patients With Rheumatic Diseases. Arthritis care & research, vol. 74, p. 1745-1750.
  16. Gorodensky, J. H., Bernatsky, S., Afif, W., Filion, K. B. & Vinet, É. (2021). Ustekinumab safety in pregnancy: a comprehensive review. Arthritis care & research.
  17. Lazarus, J. V., Safreed-Harmon, K., Kamarulzaman, A., Anderson, J., Leite, R. B., Behrens, G., Bekker, L.-G., Bhagani, S., Brown, D., Brown, G., Buchbinder, S., Caceres, C., Cahn, P. E., Carrieri, P., Caswell, G., Cooke, G. S., Monforte, A. D., Dedes, N., Del Amo, J., Elliott, R., El-Sadr, W. M., Fuster-Ruiz de Apodaca, M. J., Guaraldi, G., Hallett, T., Harding, R., Hellard, M., Jaffar, S., Kall, M., Klein, M., Lewin, S. R., Mayer, K., Pérez-Molina, J. A., Moraa, D., Naniche, D., Nash, D., Noori, T., Pozniak, A., Rajasuriar, R., Reiss, P., Rizk, N., Rockstroh, J., Romero, D., Sabin, C., Serwadda, D. & Waters, L. (2021). Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV. Nature communications, vol. 12, p. 4450.
  18. Belmesk, L., Muntyanu, A., Cantin, E., AlHalees, Z., Jack, C. S., Le, M., Sasseville, D., Iannattone, L., Ben-Shoshan, M., Litvinov, I. V. & Netchiporouk, E. (2021). Prominent Role of Type 2 Immunity in Skin Diseases: Beyond Atopic Dermatitis. Journal of cutaneous medicine and surgery, vol. 26, p. 33-49.
  19. Gyorkos, T. W., Carabin, H., Phillip, M., Benedict, L., Davis, A., Hatcher Roberts, J., Wasan, K. M., Ndao, M. & Krentel, A. (2021). Canadian contributions to research on neglected tropical diseases. PLoS neglected tropical diseases, vol. 15, p. e0009476.
  20. Alhinai, A., Patel, K., Fonseca, V. A. & Sebastiani, G. (2021). Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes. Journal of diabetes and its complications, vol. 35, p. 107978.
  21. Cao, X.-F., Li, Y., Xin, H.-N., Zhang, H.-R., Pai, M. & Gao, L. (2021). Application of artificial intelligence in digital chest radiography reading for pulmonary tuberculosis screening. Chronic diseases and translational medicine, vol. 7, p. 35-40.
  22. Shengir, M., Elgara, M. & Sebastiani, G. (2021). Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond. World journal of gastroenterology, vol. 27, p. 1959-1972.
  23. Akiyama, M. J., Kronfli, N., Cabezas, J., Sheehan, Y., Thurairajah, P. H., Lines, R., Lloyd, A. R. & International Network on Health and Hepatitis in Substance Users–Prisons Network (2021). Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework. The lancet. Gastroenterology & hepatology, vol. 6, p. 391-400.
  24. Amoako, A., Ortiz-Paredes, D., Engler, K., Lebouché, B. & Klein, M. B. (2021). Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis. The International journal on drug policy, vol. 96, p. 103247.
  25. Nissen, C. B., Sciascia, S., de Andrade, D., Atsumi, T., Bruce, I. N., Cron, R. Q., Hendricks, O., Roccatello, D., Stach, K., Trunfio, M., Vinet, É. & Schreiber, K. (2021). The role of antirheumatics in patients with COVID-19. The Lancet. Rheumatology, vol. 3, p. e447-e459.

Clinique

  1. Ouchene, L., Muntyanu, A., Assayag, D., Veilleux, E., Abril, A., Ferrara, G., Yacyshyn, E., Pineau, C. A., O'Brien, E., Baron, M., Osman, M., Gniadecki, R. & Netchiporouk, E. (2022). Skin disorders and interstitial lung disease: Part II. The spectrum of cutaneous diseases with lung disease association. Journal of the American Academy of Dermatology.
  2. McDonald, E. G., Prosty, C., Hanula, R., Bortolussi-Courval NClin, É., Albuquerque, A., Tong, S. Y. C., Hamilton, F., Lee, T. C., McDonald, E. G., Prosty, C., Hanula, R., Bortolussi-Courval NClin, É., Albuquerque, A., Tong, S. Y. C., Hamilton, F. & Lee, T. C. (2022). Observational vs. Randomized Controlled Trials to Inform Antibiotic Treatment Durations:A Narrative Review. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
  3. Hahn, G. D., Golovics, P. A., Wetwittayakhlang, P., Santa Maria, D. M., Britto, U., Wild, G. E., Afif, W., Bitton, A., Bessissow, T. & Lakatos, P. L. (2022). Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Journal of clinical medicine, vol. 11.
  4. Kouyoumdjian, A., Tchervenkov, J. & Paraskevas, S. (2022). TFNR2 in Ischemia-Reperfusion Injury, Rejection, and Tolerance in Transplantation. Frontiers in immunology, vol. 13, p. 903913.
  5. Albuquerque, A. M., Eckert, I., Tramujas, L., Butler-Laporte, G., McDonald, E. G., Brophy, J. M. & Lee, T. C. (2022). Effect of Tocilizumab, Sarilumab, and Baricitinib on Mortality Among Patients Hospitalized for COVID-19 Treated with Corticosteroids: A Systematic Review and Meta-Analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
  6. Tornai, D., Ven, P. L., Lakatos, P. L. & Papp, M. (2022). Serological biomarkers for management of primary sclerosing cholangitis. World journal of gastroenterology, vol. 28, p. 2291-2301.
  7. Bai, A. D., Lo, C. K., Komorowski, A. S., Suresh, M., Guo, K., Garg, A., Tandon, P., Senecal, J., Corpo, O. D., Stefanova, I., Fogarty, C., Butler-Laporte, G., McDonald, E. G., Cheng, M. P., Morris, A. M., Loeb, M. & Lee, T. C. (2022). Staphylococcus aureus bacteremia mortality across country income groups: A secondary analysis of a systematic review. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, vol. 122, p. 405-411.
  8. Wetwittayakhlang, P., Al Khoury, A., Hahn, G. D. & Lakatos, P. L. (2022). The Optimal Management of Fistulizing Crohn's Disease: Evidence beyond Randomized Clinical Trials. Journal of clinical medicine, vol. 11.
  9. Lee, T. C., Murthy, S., Del Corpo, O., Senécal, J., Butler-Laporte, G., Sohani, Z. N., Brophy, J. M. & McDonald, E. G. (2022). Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 28, p. 1203-1210.
  10. Hahn, G. D., Golovics, P. A., Wetwittayakhlang, P., Al Khoury, A., Bessissow, T. & Lakatos, P. L. (2022). Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?. Biomedicines, vol. 10.
  11. de-Madaria, E., Mira, J. J., Carrillo, I., Afif, W., Ang, D., Antelo, M., Bollipo, S., Castells, A., Chahal, P., Heinrich, H., Law, J. K., van Leerdam, M. E., Lens, S., Pannala, R., Park, S. H., Rabiee, A., Savarino, E. V., Singh, V. K., Vargo, J., Charabaty, A. & Drenth, J. P. H. (2022). The present and future of gastroenterology and hepatology: an international SWOT analysis (the GASTROSWOT project). The lancet. Gastroenterology & hepatology, vol. 7, p. 485-494.
  12. Papamichael, K., Afif, W., Drobne, D., Dubinsky, M. C., Ferrante, M., Irving, P. M., Kamperidis, N., Kobayashi, T., Kotze, P. G., Lambert, J., Noor, N. M., Roblin, X., Roda, G., Vande Casteele, N., Yarur, A. J., Arebi, N., Danese, S., Paul, S., Sandborn, W. J., Vermeire, S., Cheifetz, A. S., Peyrin-Biroulet, L. & International Consortium for Therapeutic Drug Monitoring (2022). Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives. The lancet. Gastroenterology & hepatology, vol. 7, p. 171-185.
  13. McDonald, E. G., Butler-Laporte, G., Del Corpo, O., Hsu, J. M., Lawandi, A., Senecal, J., Sohani, Z. N., Cheng, M. P. & Lee, T. C. (2021). On the Treatment of Pneumocystis jirovecii Pneumonia: Current Practice Based on Outdated Evidence. Open forum infectious diseases, vol. 8, p. ofab545.
  14. Wetwittayakhlang, P., Lontai, L., Gonczi, L., Golovics, P. A., Hahn, G. D., Bessissow, T. & Lakatos, P. L. (2021). Treatment Targets in Ulcerative Colitis: Is It Time for All In, including Histology?. Journal of clinical medicine, vol. 10.
  15. Gorodensky, J. H., Bernatsky, S., Afif, W., Filion, K. B. & Vinet, É. (2021). Ustekinumab safety in pregnancy: a comprehensive review. Arthritis care & research.
  16. Albader, F., Golovics, P. A., Gonczi, L., Bessissow, T., Afif, W. & Lakatos, P. L. (2021). Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring. World journal of gastroenterology, vol. 27, p. 6231-6247.
  17. Jones, J. L., Tse, F., Carroll, M. W., deBruyn, J. C., McNeil, S. A., Pham-Huy, A., Seow, C. H., Barrett, L. L., Bessissow, T., Carman, N., Melmed, G. Y., Vanderkooi, O. G., Marshall, J. K. & Benchimol, E. I. (2021). Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines. Journal of the Canadian Association of Gastroenterology, vol. 4, p. e72-e91.
  18. Benchimol, E. I., Tse, F., Carroll, M. W., deBruyn, J. C., McNeil, S. A., Pham-Huy, A., Seow, C. H., Barrett, L. L., Bessissow, T., Carman, N., Melmed, G. Y., Vanderkooi, O. G., Marshall, J. K. & Jones, J. L. (2021). Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines. Journal of the Canadian Association of Gastroenterology, vol. 4, p. e59-e71.
  19. Cheifetz, A. S., Abreu, M. T., Afif, W., Cross, R. K., Dubinsky, M. C., Loftus, E. V., Osterman, M. T., Saroufim, A., Siegel, C. A., Yarur, A. J., Melmed, G. Y. & Papamichael, K. (2021). A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease. The American journal of gastroenterology, vol. 116, p. 2014-2025.
  20. Lee, T., Cau, A., Cheng, M. P., Levin, A., Lee, T. C., Vinh, D. C., Lamontagne, F., Singer, J., Walley, K. R., Murthy, S., Patrick, D., Rewa, O. G., Winston, B. W., Marshall, J., Boyd, J., Tran, K., Kalil, A. C., Mcculoh, R., Fowler, R., Luther, J. M., Russell, J. A. & ARBs CORONA (2021). Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors. CJC open, vol. 3, p. 965-975.
  21. Falutz, J., Brañas, F. & Erlandson, K. M. (2021). Frailty: the current challenge for aging people with HIV. Current opinion in HIV and AIDS, vol. 16, p. 133-140.
  22. Restellini, S. & Afif, W. (2021). Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease. Journal of clinical medicine, vol. 10.
  23. Murthy, S. & Lee, T. C. (2021). IL-6 blockade for COVID-19: a global scientific call to arms. The Lancet. Respiratory medicine, vol. 9, p. 438-440.
  24. Pullen, M. F., Pastick, K. A., Williams, D. A., Nascene, A. A., Bangdiwala, A. S., Okafor, E. C., Hullsiek, K. H., Skipper, C. P., Lofgren, S. M., Engen, N., Abassi, M., McDonald, E. G., Lee, T. C., Rajasingham, R. & Boulware, D. R. (2021). Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic. Open forum infectious diseases, vol. 8, p. ofaa602.
  25. D'Silva, K. M., Mehta, R., Mitchell, M., Lee, T. C., Singhal, V., Wilson, M. G. & McDonald, E. G. (2021). Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

]

Campus de l'Université McGill

  1. Markarian, N. M., Galli, G., Patel, D., Hemmings, M., Nagpal, P., Berghuis, A. M., Abrahamyan, L. & Vidal, S. M. (2022). Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary Immunodeficiency. Frontiers in microbiology, vol. 13, p. 933983.
  2. Mancini, M. & Vidal, S. M. (2020). Mechanisms of Natural Killer Cell Evasion Through Viral Adaptation. Annual review of immunology, vol. 38, p. 511-539.
  3. Mancini, M. & Vidal, S. M. (2018). Insights into the pathogenesis of herpes simplex encephalitis from mouse models. Mammalian genome : official journal of the International Mammalian Genome Society, vol. 29, p. 425-445.
  4. Kang, E., Crouse, A., Chevallier, L., Pontier, S. M., Alzahrani, A., Silué, N., Campbell-Valois, F.-X., Montagutelli, X., Gruenheid, S. & Malo, D. (2018). Enterobacteria and host resistance to infection. Mammalian genome : official journal of the International Mammalian Genome Society, vol. 29, p. 558-576.